Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
about
My experience learning about autismIs Oxytocin Application for Autism Spectrum Disorder Evidence-Based?Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review.Autism: an emerging 'neuroimmune disorder' in search of therapy.Social 'wanting' dysfunction in autism: neurobiological underpinnings and treatment implications.Pharmacotherapy for the core symptoms in autistic disorder: current status of the researchThe cyclic AMP phenotype of fragile X and autismRedox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.Theoretical aspects of autism: biomarkers--a review.Management of Severe Developmental Regression in an Autistic Child with a 1q21.3 Microdeletion and Self-Injurious Blindness.The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.Buspirone for autistic disorder in a woman with an intellectual disability.Use of drawings in children with pervasive developmental disorder during hospitalization: a developmental perspective.Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.
P2860
Q24630108-084865D7-0A4C-45E4-9479-01636A5F9A1CQ26771760-0B282528-C445-477C-A5DF-8481B5086A06Q34407949-C475ECE0-E87F-4B0D-8B78-5EF879E85FC4Q34994653-E3A8DF14-5475-45F5-9C84-79B250A4B407Q36217714-9F9804BD-AD20-47CA-BD43-00AD59B4DFA6Q36784208-A5A63FD7-4562-499E-9BF2-5210C1F07427Q37097136-59E309F2-C53A-40B1-A442-89D64B1C8643Q37661363-667E8DF7-03FC-485F-925D-48C935012A70Q37836872-402F1A0B-D5E9-4140-A644-8E921293370EQ42215308-0E8E827E-FAD4-454B-9A20-439D9C403678Q43091869-0660979F-1B48-4064-8087-3E83F9C0EEEEQ46868346-2DA0159D-28DC-480F-A186-8FAB5EE85434Q50766340-BEB09E38-6234-4EB6-8EB0-4EAA6BFAA26DQ55180784-05D71878-A40E-49A6-8AFF-31FBB72CF513
P2860
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@ast
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@en
type
label
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@ast
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@en
prefLabel
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@ast
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@en
P2093
P2860
P356
P1476
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
@en
P2093
Gladys M Elchaar
Heidi J Wehring
Laura M Gianni Augusto
Nicole M Maisch
P2860
P304
P356
10.1345/APH.1G499
P407
P577
2006-05-30T00:00:00Z